These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 7794549)

  • 21. Variability analysis of HIV-1 gp120 V3 region: I. Point estimators for the amino acid distribution characteristics.
    Shchelkanov MYu ; Yudin AN; Antonov AV; Starikov NS; Vedenov AA; Karamov EV
    J Biomol Struct Dyn; 1997 Oct; 15(2):217-29. PubMed ID: 9399150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SIVmac expressing hybrid envelope proteins containing HIV-1 V3 and/or C4 sequences is not competent for replication.
    Kirchhoff F; Morrison HG; Murray MG; Rennert P; Desrosiers RC
    AIDS Res Hum Retroviruses; 1994 Mar; 10(3):309-13. PubMed ID: 8018392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenotypic switch in a Spanish HIV type 1 isolate on serial passage on MT-4 cells.
    Olivares I; Shaw G; Lopez-Galindez C
    AIDS Res Hum Retroviruses; 1997 Jul; 13(11):979-84. PubMed ID: 9223414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sequence variation and consensus sequence of V3 loop on HIV-1 gp120.
    Tian H; Lan C; Chen YH
    Immunol Lett; 2002 Oct; 83(3):231-3. PubMed ID: 12095714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drift from the GPGRAF HIV-1 envelope V3 crown sequence in a North American inner city.
    Rencher SD; Lockey TD; Slobod KS; Hurwitz JL
    AIDS Res Hum Retroviruses; 1997 Apr; 13(6):527-8. PubMed ID: 9100996
    [No Abstract]   [Full Text] [Related]  

  • 26. Genetic polymorphism of envelope V3 region of HIV type 1 subtypes A, C, and D from Nairobi, Kenya.
    Zachar V; Goustin AS; Zacharova V; Hager H; Koppelhus U; Womble DD; Liu X; Bambra C; Nyongo A; Ebbesen P
    AIDS Res Hum Retroviruses; 1996 Jan; 12(1):75-8. PubMed ID: 8825622
    [No Abstract]   [Full Text] [Related]  

  • 27. Characterization of the V3 region of HIV type 1 isolates from Morocco.
    Abid M; Luo CC; Sekkat S; De Latore N; Mansour H; Holloman-Candal D; Rayfield M; Benslimane A
    AIDS Res Hum Retroviruses; 1998 Oct; 14(15):1387-9. PubMed ID: 9788680
    [No Abstract]   [Full Text] [Related]  

  • 28. HIV-1 intrapatient sequence diversity in the immunogenic V3 region.
    Korber B; Wolinsky S; Haynes B; Kunstman K; Levy R; Furtado M; Otto P; Myers G
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1461-5. PubMed ID: 1281659
    [No Abstract]   [Full Text] [Related]  

  • 29. Silent mutation pattern in V3 sequences distinguishes virus according to risk group in Europe.
    Kuiken CL; Goudsmit J
    AIDS Res Hum Retroviruses; 1994 Mar; 10(3):319-20. PubMed ID: 8018394
    [No Abstract]   [Full Text] [Related]  

  • 30. V3-mediated heparin neutralization of HIV type 1.
    Javaherian K; Khiroya R; Quinlan C; Boyd JG; Hanham KA
    AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1421-3. PubMed ID: 7888195
    [No Abstract]   [Full Text] [Related]  

  • 31. Human immunodeficiency virus type 1 tropism for T-lymphoid cell lines: role of the V3 loop and C4 envelope determinants.
    Carrillo A; Ratner L
    J Virol; 1996 Feb; 70(2):1301-9. PubMed ID: 8551600
    [No Abstract]   [Full Text] [Related]  

  • 32. Macrophage-tropism of HIV-1 isolates of different genetic subtypes.
    Karita E; Nkengasong JN; Willems B; Vanham G; Fransen K; Heyndrickx L; Janssens W; Piot P; van der Groen G
    AIDS; 1997 Aug; 11(10):1303-4. PubMed ID: 9256957
    [No Abstract]   [Full Text] [Related]  

  • 33. HIV gp120 V(1)/V(2) and C(2)-V(3) domains glycoprotein compatibility is required for viral replication.
    Chen M; Shi C; Kalia V; Tencza SB; Montelaro RC; Gupta P
    Virus Res; 2001 Nov; 79(1-2):91-101. PubMed ID: 11551649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An efficient system for site-directed mutagenesis to make various mutants of the env gene of human immunodeficiency virus type 1.
    Shimizu N; Hoshino H
    FEBS Lett; 1998 Jul; 430(3):333-7. PubMed ID: 9688566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic analysis of V3 domain sequences obtained from Uruguayan HIV type 1-infected individuals.
    Fernández Medina RD; Jansson M; Halapi E; Russi JC; Libonatti O; Wigzell H
    AIDS Res Hum Retroviruses; 1996 Oct; 12(15):1491-3. PubMed ID: 8893057
    [No Abstract]   [Full Text] [Related]  

  • 36. Macrophage tropism determinants of human immunodeficiency virus type 1 in vivo.
    Westervelt P; Trowbridge DB; Epstein LG; Blumberg BM; Li Y; Hahn BH; Shaw GM; Price RW; Ratner L
    J Virol; 1992 Apr; 66(4):2577-82. PubMed ID: 1548783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The highly conserved aspartic acid residue between hypervariable regions 1 and 2 of human immunodeficiency virus type 1 gp120 is important for early stages of virus replication.
    Wang WK; Essex M; Lee TH
    J Virol; 1995 Jan; 69(1):538-42. PubMed ID: 7983752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of HIV type 1 infectivity by coexpression of a wild-type and a defective glycoprotein 120.
    Lund OS; Losman B; Schønning K; Bolmstedt A; Olofsson S; Hansen JE
    AIDS Res Hum Retroviruses; 1998 Nov; 14(16):1445-50. PubMed ID: 9824322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Susceptibility to highly sulphated glycosaminoglycans of human immunodeficiency virus type 1 replication in peripheral blood lymphocytes and monocyte-derived macrophages cell cultures.
    Bartolini B; Di Caro A; Cavallaro RA; Liverani L; Mascellani G; La Rosa G; Marianelli C; Muscillo M; Benedetto A; Cellai L
    Antiviral Res; 2003 Apr; 58(2):139-47. PubMed ID: 12742574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Likelihood models for detecting positively selected amino acid sites and applications to the HIV-1 envelope gene.
    Nielsen R; Yang Z
    Genetics; 1998 Mar; 148(3):929-36. PubMed ID: 9539414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.